Mark Stoneley

4k citations

33 papers · 2.9k · 1 hit paper · h-index 23

Impact in

Molecular Biology top 2%
- RNA and protein synthesis mechanisms
- RNA Research and Splicing
- PI3K/AKT/mTOR signaling in cancer
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
Cancer Research top 10%
- MicroRNA in disease regulation

Papers in

Molecular Biology 31
- RNA and protein synthesis mechanisms 26
- RNA Research and Splicing 6
- PI3K/AKT/mTOR signaling in cancer 5
- Nuclear Structure and Function 2
- Mitochondrial Function and Pathology 1
- Metabolism, Diabetes, and Cancer 1
Aging 1

Co-authors: Anne E. Willis (27 shared papers)Keith A. Spriggs (9 shared papers)Martin Bushell (9 shared papers)Stephen A. Chappell (3 shared papers)John P. C. Le Quesne (2 shared papers)F. Paulin (2 shared papers)Marion MacFarlane (3 shared papers)Michelle J. West (1 shared paper)
Journals: Oncogene (6 papers)Nucleic Acids Research (4 papers)Molecular Cell (4 papers)Biochemical Society Transactions (3 papers)Molecular and Cellular Biology (3 papers)
Partner nations: United Kingdom United States Switzerland

In The Last Decade

Mark Stoneley

31 papers receiving 2.8k citations

Mark Stoneley's Hit Papers

align trajectories log scale

N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting 2023 · 166 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2023 Nature

Peers

Countries citing papers authored by Mark Stoneley

Since Specialization

Citations

This map shows the geographic impact of Mark Stoneley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stoneley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stoneley more than expected).

Fields of papers citing papers by Mark Stoneley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Stoneley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stoneley. The network helps show where Mark Stoneley may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Stoneley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Stoneley Line = papers co-authored together Mark Stoneley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	C-Myc 5′ untranslated region contains an internal ribosome entry segment Oncogene ·Mark Stoneley, F. Paulin, John P. C. Le Quesne, Stephen A. Chappell, Anne E. Willis	1998	289
2	Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression Oncogene ·Mark Stoneley, Anne E. Willis	2004	289
3	Re‐programming of translation following cell stress allows IRES‐mediated translation to predominate Biology of the Cell ·Keith A. Spriggs, Mark Stoneley, Martin Bushell, Anne E. Willis	2007	232
4	c-Myc Protein Synthesis Is Initiated from the Internal Ribosome Entry Segment during Apoptosis Molecular and Cellular Biology ·Mark Stoneley, Stephen A. Chappell, Catherine L. Jopling, Martin Dickens, Marion MacFarlane, Anne E. Willis	2000	188
5	Initiation of Apaf-1 translation by internal ribosome entry Oncogene ·Mark J. Coldwell, Mark Stoneley, Marion MacFarlane, Anne E. Willis +1 other	2000	173
6	N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting Nature ·Thomas E. Mulroney, Tuija A. A. Pöyry, Juan Carlos Yam‐Puc, Maria A. Rust, Robert F. Harvey, Lajos Kalmár, Emily C. Horner, Lucy H. Booth Hit paper breakdown →	2023	166
7	Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment Nucleic Acids Research ·Mark Stoneley	2000	164
8	Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway Oncogene ·Michelle J. West, Mark Stoneley, Anne E. Willis	1998	163
9	The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene Proceedings of the National Academy of Sciences ·Yi Wen Kong, Ian Gordon Cannell, Cornelia H. de Moor, Kirsti Hill, Paul G. Garside, Tiffany L. Hamilton, Hedda A. Meijer, Helen C. Dobbyn	2008	158
10	Polypyrimidine Tract Binding Protein Regulates IRES-Mediated Gene Expression during Apoptosis Molecular Cell ·Martin Bushell, Mark Stoneley, Yi Wen Kong, Tiffany L. Hamilton, Keith A. Spriggs, Helen C. Dobbyn, Xiaoli Qin, Peter Sarnow	2006	126
11	A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: A novel mechanism of oncogene de-regulation Oncogene ·Stephen A. Chappell, John P. C. Le Quesne, F. Paulin, Matthew L. deSchoolmeester, Mark Stoneley, Richard L Soutar, Stuart H. Ralston, Miep Helfrich	2000	114
12	RNA Binding Protein/RNA Element Interactions and the Control of Translation Current Protein and Peptide Science ·Xavier Pichon, Lindsay A. Wilson, Mark Stoneley, Amandine Bastide, Helen A. King, Joanna Somers, Anne E. Willis	2012	114
13	ROS-induced ribosome impairment underlies ZAKα-mediated metabolic decline in obesity and aging Science ·Goda Snieckute, Laura Ryder, Frederic Schrøder Arendrup, Mark Stoneley, Sébastien Chamois, Ana Martínez‐Val, Marion Leleu, René Dreos	2023	99
14	Bag-1 Internal Ribosome Entry Segment Activity Is Promoted by Structural Changes Mediated by Poly(rC) Binding Protein 1 and Recruitment of Polypyrimidine Tract Binding Protein 1 Molecular and Cellular Biology ·Becky M. Pickering, Keith A. Spriggs, Mark Stoneley, Anne E. Willis +1 other	2004	77
15	Unresolved stalled ribosome complexes restrict cell-cycle progression after genotoxic stress Molecular Cell ·Mark Stoneley, Robert F. Harvey, Thomas E. Mulroney, Ryan Mordue, Rebekah Jukes‐Jones, Kelvin Cain, Kathryn Susan Lilley, Ritwick Sawarkar	2022	68
16	TOPs and their regulation Biochemical Society Transactions ·Tiffany L. Hamilton, Mark Stoneley, Keith A. Spriggs, Martin Bushell	2006	67
17	Ribosome stalling is a signal for metabolic regulation by the ribotoxic stress response Cell Metabolism ·Goda Snieckute, Aitana Victoria Genzor, Anna Vind, Laura Ryder, Mark Stoneley, Sébastien Chamois, René Dreos, Cathrine Nordgaard	2022	66
18	Canonical Initiation Factor Requirements of the Myc Family of Internal Ribosome Entry Segments Molecular and Cellular Biology ·Keith A. Spriggs, Laura C. Cobbold, Catherine L. Jopling, Rebecca E. Cooper, Lindsay A. Wilson, Mark Stoneley, Mark J. Coldwell, Didier Poncet	2009	55
19	Translation inhibition during the induction of apoptosis: RNA or protein degradation? Biochemical Society Transactions ·Martin Bushell, Mark Stoneley, Peter Sarnow, Anne E. Willis	2004	46
20	L-Myc protein synthesis is initiated by internal ribosome entry RNA ·Catherine L. Jopling, Keith A. Spriggs, Mark Stoneley, Anne E. Willis +1 other	2004	43

About Mark Stoneley

Mark Stoneley is a scholar working on Molecular Biology, Aging, Toxicology, Genetics and Cancer Research, having authored 33 papers that have together received 2.9k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (26 papers), RNA Research and Splicing (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Nuclear Structure and Function (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Mitochondrial Function and Pathology (1 paper), Bioactive Compounds and Antitumor Agents (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Molecular Biology (2.2k citations), Cancer Research (221 citations), Aging (23 citations), Cell Biology (90 citations) and Oncology (140 citations). Mark Stoneley has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Anne E. Willis, Keith A. Spriggs, Martin Bushell, Stephen A. Chappell, John P. C. Le Quesne, F. Paulin, Marion MacFarlane, Michelle J. West, Catherine L. Jopling and Tiffany L. Hamilton. Their work appears in journals such as Oncogene, Nucleic Acids Research, Molecular Cell, Biochemical Society Transactions and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark Stoneley

Impact in

Papers in i

In The Last Decade

Mark Stoneley

Mark Stoneley's Hit Papers

Peers

Countries citing papers authored by Mark Stoneley

Fields of papers citing papers by Mark Stoneley

All Works

About Mark Stoneley

Explore authors with similar magnitude of impact

Papers in